Author: Hossam Elgnainy

No, azithromycin should not be used solely as an immunomodulator for acute chest infections in infants under 1 year. why: ​Lack of Clinical Benefit: Studies show its anti-inflammatory properties do...

Why Azithromycin is Not Routine ​Viral Dominance: The vast majority of lower respiratory tract infections in infants under 1 year (such as bronchiolitis) are viral in origin, most commonly Respiratory...

No, azithromycin is not routinely used as a first-line or empirical treatment for chest infections in infants less than 1 year of age. Its use in this age group is reserved for specific, confirmed, or...

Can you please, state your question?

Nebulized furosemide doses of 1 or 2 mg/kg may be effective in improving pulmonary mechanics in preterm infants with BPD, but recommendations on frequency and duration of therapy are limited. 1 mg/kg...

There is no single comprehensive source for pediatric ECMO drug dosing, as evidence is limited and varies by drug, age, and circuit type. The best approach is to combine data from key reviews (e.g., Raffaeli...

I can refer you to this article, Infective Endocarditis in Children: https://www.dynamed.com/topic/T1732548400906

The answer to this question can take hours to explain. Can you be more specific about the patient?

Silymarin is not strictly contraindicated in hepatitis A infection, but generally not recommended in children because of insufficient safety and efficacy data.

Here’s a concise summary with rationale for antibiotic use in road traffic accidents (RTA): 1. Open Fractures Type I–II: Cefazolin (1st-gen cephalosporin). 🔹 Rationale: covers skin flora (Staph/Strep);...

When you say RTAs, do you mean road traffic accidents (trauma cases) or renal tubular acidosis? Both use the same abbreviation but have completely different clinical contexts — and antibiotic management...